News & Analysis on Clinical Trial Services & Contract Research And Development
Cambrex posted a 5 per cent hike in revenues in the second quarter, helped by its shift into contract controlled substance manufacture, although without favourable currency effects sales would have slipped back 2.6 per cent.
A new report predicts that current global sales leader Pfizer will relinquish its position by 2014 leaving European pharmaceutical producers like Roche and Sanofi-Aventis free to vie for the top spot.
Pharmaceutical company Enzon may hive off its entire specialty drugs division, including a manufacturing facility in Indianapolis, US, in the face of pressure from shareholder Carl Icahn.
Researchers claim to have facilitated the development and manufacture of a wide range of alkaloids using genetically modified yeast.
Venus Remedies’ oncology facility has received EMEA GMP accreditation, making it one of very few Indian contract manufacturers licensed to make cancer treatments for the European market.